Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection
出版年份 2018 全文链接
标题
Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection
作者
关键词
-
出版物
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-08-31
DOI
10.1038/s41395-018-0217-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparison of AOC and AOM Triple, Sequential, and Concomitant Therapy as the First Line Eradication Therapy for Helicobacter Pylori
- (2017) Jin Il Kim GASTROENTEROLOGY
- Illusions regardingHelicobacter pyloriclinical trials and treatment guidelines
- (2017) David Y Graham GUT
- Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies
- (2017) Javier P. Gisbert et al. HELICOBACTER
- Ten-day empirical sequential or concomitant therapy is more effective than triple therapy for Helicobacter pylori eradication: A multicenter, prospective study
- (2016) Jun-Won Chung et al. DIGESTIVE AND LIVER DISEASE
- Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication
- (2016) Bojan Tepeš et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area
- (2016) Sotirios D. Georgopoulos et al. European Journal of Internal Medicine
- The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
- (2016) Carlo A. Fallone et al. GASTROENTEROLOGY
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
- (2016) Jyh-Ming Liou et al. LANCET
- Nonbismuth concomitant quadruple therapy forHelicobacter pylorieradication in Chinese regions: A meta-analysis of randomized controlled trials
- (2016) Lien-Chieh Lin et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Optimised empiric triple and concomitant therapy forHelicobacter pylorieradication in clinical practice: the OPTRICON study
- (2015) J. Molina-Infante et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment ofHelicobacter pyloriinfection
- (2015) J.-M. Liou et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Helicobacter pylori Update: Gastric Cancer, Reliable Therapy, and Possible Benefits
- (2015) David Y. Graham GASTROENTEROLOGY
- Sequential therapy for 10 days versus triple therapy for 14 days in the eradication ofHelicobacter pyloriin the community and hospital populations: a randomised trial
- (2015) Jyh-Ming Liou et al. GUT
- Kyoto global consensus report onHelicobacter pylorigastritis
- (2015) Kentaro Sugano et al. GUT
- First-line eradication rates comparing two shortened non-bismuth quadruple regimens againstHelicobacter pylori: an open-label, randomized, multicentre clinical trial
- (2015) Antonio Cuadrado-Lavín et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ten-day triple therapyversussequential therapyversusconcomitant therapy as first-line treatment forHelicobacter pyloriinfection
- (2015) Tiing Leong Ang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Concomitant therapy achieved the best eradication rate forHelicobacter pyloriamong various treatment strategies
- (2015) Hyun Jeong Lee WORLD JOURNAL OF GASTROENTEROLOGY
- Randomized Controlled Trial Comparing 7-Day Triple, 10-Day Sequential, and 7-Day Concomitant Therapies for Helicobacter pylori Infection
- (2014) Ping-I Hsu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication
- (2014) Jun Heo et al. DIGESTIVE AND LIVER DISEASE
- Gastrointestinal: Diaphragm disease: Emerging cause of gastrointestinal obstruction and bleeding
- (2014) L Courtenay et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials
- (2014) A. C. Ford et al. BMJ-British Medical Journal
- Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance
- (2013) Javier Molina–Infante et al. GASTROENTEROLOGY
- Clinical Evaluation of a Ten-Day Regimen with Esomeprazole, Metronidazole, Amoxicillin, and Clarithromycin for the Eradication ofHelicobacter pyloriin a High Clarithromycin Resistance Area
- (2013) Sotirios D. Georgopoulos et al. HELICOBACTER
- Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
- (2013) L. Gatta et al. BMJ-British Medical Journal
- Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption
- (2012) Francis Megraud et al. GUT
- Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains
- (2012) Javier Molina-Infante et al. HELICOBACTER
- Comparative Study of Helicobacter pylori Eradication Rates With 5-day Quadruple “Concomitant” Therapy and 7-day Standard Triple Therapy
- (2012) Seung Young Kim et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Nonbismuth Quadruple “Concomitant” Therapy Versus Standard Triple Therapy, Both of the Duration of 10 Days, for First-Line H. Pylori Eradication
- (2012) Sotirios Georgopoulos et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication
- (2012) Yao-Kang HUANG et al. Journal of Digestive Diseases
- Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
- (2012) Jyh-Ming Liou et al. LANCET
- 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial
- (2011) E Robert Greenberg et al. LANCET
- Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
- (2011) Peter Malfertheiner et al. LANCET
- Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori Infection
- (2009) Deng–Chyang Wu et al. Clinical Gastroenterology and Hepatology
- Meta-analysis: Four-Drug, Three-Antibiotic, Non-bismuth-Containing “Concomitant Therapy” Versus Triple Therapy forHelicobacter pyloriEradication
- (2009) Abdallah Said Essa et al. HELICOBACTER
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
- (2009) Alessandro Liberati et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now